Asia & Pacific Legal Chronicle. August 3, 2024

Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare

By Georgio Naffaa

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here